Threshold Suspend in Pediatrics at Home

NACompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 16, 2017

Study Completion Date

June 16, 2017

Conditions
Type 1 Diabetes
Interventions
DEVICE

530G Insulin pump

Subjects will use 530G insulin pump with Threshold Suspend (TS) feature for one year.

Trial Locations (16)

11733

Stony Brook Children's Hospital, East Setauket

19104

Children's Hospital of Philadelphia, Philadelphia

32207

Nemours Children's Health System, Jacksonville

55102

Children's Hospital and Clinics of Minnesota, Saint Paul

55416

Park Nicollet Clinic - International Diabetes Center, Minneapolis

55454

University of Minnesota Pediatric Endocrinology Clinic, Minneapolis

77030

Texas Children Hospital/Baylor College of Medicine, Houston

80045

University of Colorado Health Science Center, Barbara Davis Center for Childhood Diabetes, Aurora

89148

The Pediatric and Endocrine Diabetes Specialists, Las Vegas

90027

Children's Hospital Los Angeles, Los Angeles

90505

SoCal Diabetes, Torrance

92868

Children's Hospital of Orange County, Orange

94158

Madison Clinic for Pediatric Diabetes at UCSF, San Francisco

94305

Stanford University, Stanford

95821

Sutter Institute for Medical Research Excellence in Diabetes and Endocrinology, Sacramento

06519

Yale University School of Medicine, New Haven

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT02120794 - Threshold Suspend in Pediatrics at Home | Biotech Hunter | Biotech Hunter